Natixis’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
Other funds holding BNTX
Natixis's BNTX Position: Q1 2026 in Review
Natixis sold out of BioNTech (BNTX) in Q1 2026, closing a stake of 635 shares — an estimated $60.5K sold.
Natixis first reported a position in BNTX in Q3 2020 and held it in 17 quarters. The position peaked at $21.2M in Q3 2020. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.
- Natixis reported no remaining BioNTech position as of Q1 2026 after selling out during the quarter.
- Natixis sold 635 BioNTech shares in Q1 2026, an estimated $60.5K.
- Natixis first reported a position in BioNTech in Q3 2020 and held it in 17 quarters.
- Natixis's BioNTech position peaked at $21.2M in Q3 2020.
- 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.
Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.